- Home
- STRO vs BFAC Comparison
STRO vs BFAC Comparison
Compare STRO & BFAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- BFAC
- Stock Information
- Founded
- STRO 2003
- BFAC 2021
- Country
- STRO United States
- BFAC United States
- Employees
- STRO N/A
- BFAC N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- BFAC Blank Checks
- Sector
- STRO Health Care
- BFAC Finance
- Exchange
- STRO Nasdaq
- BFAC Nasdaq
- Market Cap
- STRO 172.8M
- BFAC 152.7M
- IPO Year
- STRO 2018
- BFAC 2021
- Fundamental
- Price
- STRO $2.08
- BFAC $11.14
- Analyst Decision
- STRO Strong Buy
- BFAC
- Analyst Count
- STRO 7
- BFAC 0
- Target Price
- STRO $12.14
- BFAC N/A
- AVG Volume (30 Days)
- STRO 1.4M
- BFAC 4.3K
- Earning Date
- STRO 11-13-2024
- BFAC 01-01-0001
- Dividend Yield
- STRO N/A
- BFAC N/A
- EPS Growth
- STRO N/A
- BFAC 49.83
- EPS
- STRO N/A
- BFAC 0.37
- Revenue
- STRO $160,955,000.00
- BFAC N/A
- Revenue This Year
- STRO N/A
- BFAC N/A
- Revenue Next Year
- STRO N/A
- BFAC N/A
- P/E Ratio
- STRO N/A
- BFAC $29.86
- Revenue Growth
- STRO 230.90
- BFAC N/A
- 52 Week Low
- STRO $2.04
- BFAC $10.84
- 52 Week High
- STRO $6.13
- BFAC $11.55
- Technical
- Relative Strength Index (RSI)
- STRO 28.56
- BFAC 55.51
- Support Level
- STRO $2.66
- BFAC $11.13
- Resistance Level
- STRO $3.01
- BFAC $11.15
- Average True Range (ATR)
- STRO 0.19
- BFAC 0.00
- MACD
- STRO -0.04
- BFAC 0.00
- Stochastic Oscillator
- STRO 5.64
- BFAC 75.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About BFAC Battery Future Acquisition Corp.
Battery Future Acquisition Corp is a blank check company.